Convexia Launches: World’s First AI-Maximalist Pharma Company
"Uncover Drug Assets 10x faster"
TL;DR: An AI-maximalist pharma company. They buy drugs, run clinical trials, and then sell for profit.
Founded by Ayaan Parikh & Rahul Vijayan
Problem
Pharma is the most bloated, antiquated trillion-dollar industry on the planet.
Life-saving drugs are overlooked, abandoned, or shelved because diligence is still done by hand. Slow, costly, and outdated.
Their Solution
Convexia uses agents to operate 10x faster and 20x leaner. Convexia’s AI agents autonomously handle:
- Sourcing – Find hidden early-stage drugs from around the world.
- Scientific diligence – Evaluate drug viability with leading computational biology tools
- Market analysis – Model market size, competition, and IP positioning
- Clinical operations – Simulate trials, flag CMC issues, and discover CROs
- Business development – Match each drug to the right buyer
Test their agents here: https://www.convexia.bio/playground

Their Ask
Before buying and selling drugs themselves, they are running pilots with early customers who want to accelerate their search and evaluation processes.
Here’s who they are looking to meet—see if anyone’s in your network here.
- Small/mid pharma companies (Incyte, Nimbus, Roivant SubCos)
- Biotech VCs (Versant, Atlas, RA Capital)
- Computational biotechs (Recursion, Insitro, Owkin)
- Operators who’ve brought drugs to market
Learn More
🌐 Visit www.convexia.bio to learn more.
📅 Book a call here.
📧 Reach the founders here.
👣 Follow Convexia on LinkedIn.
Simplify Startup Finances Today
Take the stress out of bookkeeping, taxes, and tax credits with Fondo’s all-in-one accounting platform built for startups. Start saving time and money with our expert-backed solutions.
Get Started